Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study
Published in The Lancet Digital Health, 2025
This publication is available via DOI.
Recommended citation: Gonzalez Dorta, H., Verbeeck, J., Crevecoeur, J., Morales, D.R., Loedy, N., Cohet, C., Willem, L., Molenberghs, G., Hens, N., Kurz, X., Quinten, C., & Abrams, S. (2025) "Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study." The Lancet Digital Health. 7(5), 100861.